Although the identification of conolidine as a potential novel analgesic agent delivers yet another avenue to deal with the opioid disaster and deal with CNCP, additional experiments are vital to understand its system of motion and utility and efficacy in managing CNCP.Conolidine isn’t simply a passing trend in ache reduction—it’s a potential